BIO News and Press, Bio-Rad Laboratories Inc. Class A From 01/02/24

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, today announced that Norman Schwartz, President and CEO, and Andrew Last, Executive Vice President and COO, will host one-on-one meetings with investors during the 42nd Ann...

2023-11-25 05:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-15 10:41:34 ET More on JFrog, Louisiana-Pacific, etc. Spectrum Brands Holdings: A Messy But Appealing Prospect Heading Into Q4 Earnings JFrog: A High-Quality Company With Little Margin of Safety Raymond James cuts Masimo to market perform, cites lack of visib...

2023-10-26 20:04:05 ET Bio-Rad Laboratories, Inc. (BIO) Q3 2023 Results Conference Call October 26, 2023 05:00 PM ET Company Participants Edward Chung - Head, IR Norman Schwartz - CEO Ilan Daskal - EVP and CFO Andy Last - EVP and COO Simon May - President...

2023-10-26 17:07:37 ET More on Bio-Rad Labs Bio-Rad: Business Returns Aren't Economically Valuable, Sartorius Now A Hindrance Bio-Rad: A Cash Flow Returns On Investments Analysis Bio-Rad Laboratories, Inc. (BIO) Q2 2023 Earnings Call Transcript Bio-Rad Labs Q...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30, 2023. Third-quarter 2023 total net sales were $632.1 million, a decrease of 7.1 percent comp...

CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...

Bio-Rad Laboratories Inc. Class A (BIO) is expected to report $2.87 for Q3 2023

2023-10-25 13:15:34 ET More on Thermo Fisher Thermo Fisher Scientific Inc. (TMO) Q3 2023 Earnings Call Transcript Thermo Fisher Scientific: Too Big For Olink To Move The Needle Thermo Fisher Scientific: Transforming Healthcare Leadership Post-COVID-19 Pandemic ...

2023-10-24 22:33:48 ET Summary Bio-Rad Laboratories' investment returns are expected to be hindered by economic and technical factors. The company's large ownership in Sartorius AG has been a hindrance due to the latter's poor performance and high correlations between the pair. ...